Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant
Prarthana J Dalal1, Pedro Giro2, Laura J Rasmussen-Torvik3
1Division of Hematology and Oncology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Insights
The ICAM1 rs5491 genetic variant increases heart failure with preserved ejection fraction (HFpEF) risk in African-American women aged 70 and older. This finding highlights age-specific genetic risks for HFpEF.
Area of Science:
- Cardiovascular Genetics
- Pharmacogenomics
- Epidemiology
Background:
- A common ICAM1 genetic variant (rs5491; p.K56M) is linked to heart failure (HF) hospitalization in African Americans.
- The specific association of rs5491 with heart failure with preserved ejection fraction (HFpEF) and its relationship with age in women remains unclear.
Purpose of the Study:
- To assess the risk of HF and its subtypes associated with the ICAM1 p.K56M (rs5491) variant.
- To investigate if age modifies the association between rs5491 and HFpEF risk in African-American women.
Main Methods:
- Utilized data from the Women's Health Initiative (WHI) cohort of African-American women to examine associations between rs5491 and HF subtypes.
- Evaluated age as a potential modifier of the rs5491-HF hospitalization link.
- Pooled data from WHI and the Multi-Ethnic Study of Atherosclerosis (MESA) for further analysis.
Main Results:
- The rs5491 variant was not associated with overall HF risk in the WHI cohort.
- Age significantly modified the association between rs5491 and HFpEF hospitalization (interaction P=0.04).
- rs5491 increased HFpEF risk in women aged 70 years and older (HR 1.82; P=0.002), an effect strengthened in the pooled WHI and MESA analysis (interaction P=0.009).
Conclusions:
- The ICAM1 p.K56M (rs5491) variant is specifically associated with an increased risk of HFpEF in African-American women aged 70 years and older.
- Age is a critical factor in the genetic susceptibility to HFpEF conferred by rs5491.
Background:
A common genetic variant of ICAM1 among African-American individuals (rs5491; p.K56M) is associated with heart failure (HF) hospitalization, but whether this risk is specific to heart failure with preserved ejection fraction (HFpEF) remains unclear. Older women are at high risk for HFpEF, and the relationship between rs5491 and HFpEF across the age spectrum is unknown.
Objectives:
This study assessed risk of HF and its subtypes conferred by ICAM1 p.K56M (rs5491).
Methods:
Associations of rs5491 with risk of HF and its subtypes were estimated among African American individuals in WHI (Women's Health Initiative). The study evaluated whether the association between rs5491 and HF hospitalizations was modified by baseline age. Subsequently, African-American women in WHI and MESA (Multi-Ethnic Study of Atherosclerosis) were pooled and analyses were repeated.
Results:
Among 8,401 women in WHI, the minor allele frequency of rs5491 was 20.7%, and 731 HF hospitalizations occurred over 19.2 years. The rs5491 variant was not associated with HF or its subtypes across WHI. Interaction analyses suggested that age as a continuous variable modified the association of rs5491 with HFpEF hospitalization (interaction P = 0.04). Upon categorizing women into age decades, rs5491 conferred increased risk of HFpEF among women ≥70 years (HR per additional rs5491 allele: 1.82 [95% CI: 1.25-2.65]; P = 0.002) but was not associated with HFpEF risk among women <70 years. Pooling African-American women in WHI (n = 8,401) and MESA (n = 856) demonstrated that the effect modification by age on the association of rs5491 with HFpEF became more significant (interaction P = 0.009), with consistent HFpEF risk effect estimates among women ≥70 years.
Conclusions:
ICAM1 p.K56M (rs5491) is associated with HFpEF among African-American women ≥70 years.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Diuretics